FDA Adverse Event Malfunction Summary report: N

COAGUCHEK ® XS SYSTEM

MDR report key: 3163120 · Received June 11, 2013

Report

Report Number
1823260-2013-03541
Event Type
Malfunction
Date Received
June 11, 2013
Date of Event
May 16, 2013
Report Date
August 2, 2013
Manufacturer
ROCHE DIAGNOSTICS
Product Code
GJS
PMA / PMN Number
NA
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

THE EVENT OCCURRED IN (B)(6). WHILE THIS PRODUCT IS NOT SOLD IN THE UNITED STATES, IT IS LIKE OR SIMILAR TO A PRODUCT MARKETED IN THE UNITED STATES.

Description of Event or Problem · 1

REPORTER STATED THAT A VENOUS SAMPLE OBTAINED FROM PATIENT WAS TESTED ON AN UNSPECIFIED LABORATORY INSTRUMENT WITH A RESULT OF 2.3 INR. ONE HOUR AND 32 MINUTES LATER, PATIENT TESTED ON THE COAGUCHEK XS SYSTEM WITH A RESULT OF 3.1 INR. NO ACTION BASED ON THE COAGUCHEK XS RESULT WAS REPORTED AND NO ADVERSE EVENT OCCURRED. THE MANUFACTURER REQUESTED THE RETURN OF THE SUSPECT PRODUCT FOR EVALUATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
264419 COAGUCHEK ® XS SYSTEM PROTHROMBIN TIME TEST STRIPS GJS ROCHE DIAGNOSTICS NA 21637422

Patients

Seq Age Sex Outcome Treatment
1 069 YR METFORMIN| COUMADIN| AVILAD| LIPITOR